Dallah Healthcare Gets Saudi CMA's Nod for Capital Increase
Dallah Healthcare (SASE:4004) secured approval from Saudi Arabia's Capital Market Authority to increase its capital by issuing one bonus share for every five existing shares held by shareholders. The healthcare company's capital will increase to 1.22 billion Saudi riyals from 1.02 billion riyals through a transfer of 109.5 million riyals from the share premium and 93.6 million riyals from the statutory reserve accounts, according to a Sunday release. The company will hold its extraordinary general assembly within six months to fulfill all regulatory requirements for the process.
Dallah Healthcare (SASE:4004) secured approval from Saudi Arabia's Capital Market Authority to increase its capital by issuing one bonus share for every five existing shares held by shareholders.
The healthcare company's capital will increase to 1.22 billion Saudi riyals from 1.02 billion riyals through a transfer of 109.5 million riyals from the share premium and 93.6 million riyals from the statutory reserve accounts, according to a Sunday release.
The company will hold its extraordinary general assembly within six months to fulfill all regulatory requirements for the process.